Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factorsLaura Pérez‐Alós, Peter Garred, Margit Anita Hørup Larsen et al.|Nature Communications|2022Cited by 192
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection riskLaura Pérez‐Alós, Peter Garred, Cecilie Bo Hansen et al.|Nature Communications|2023Cited by 53
Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy ControlsSebastian Rask Hamm, Susanne Dam Nielsen, Dina Leth Møller et al.|Frontiers in Immunology|2022Cited by 45
Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infectionOmid Rezahosseini, Susanne Dam Nielsen, Sebastian Rask Hamm et al.|Frontiers in Immunology|2023Cited by 18
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseasesZitta Barrella Harboe, Jens‐Ulrik Stæhr Jensen, Sebastian Rask Hamm et al.|BMJ Open Respiratory Research|2022Cited by 18